Eli Lilly And Company Limited
Private Limited Company · Basingstoke
ActiveUnited KingdomIncorporated 1934Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
No processed account filings
No processed accounts are available in our records.
Registered details
00284385- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 1934-02-05
- Jurisdiction
- —
- Registered office
- ELI LILLY AND COMPANY LIMITED, LILLY HOUSE, BASINGVIEW, BASINGSTOKE, HAMPSHIRE, RG21 4FA, UNITED KINGDOM
Classification
1 SIC codes23112
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
71 matched grantsImpairment Of Neural Plasticity And Adaptive Representations By Genetic Risk Factors For SchizophreniaActiveMRC · Research Grant · 2023-09-30 – 2028-09-29 · with 3 other participants£2,097,984whole project
Impairment Of Neural Plasticity And Adaptive Representations By Genetic Risk Factors For SchizophreniaActive
MRC · Research Grant · 2023-09-30 – 2028-09-29 · with 3 other participants
£2,097,984
whole project
University of BristolleadCardiff UniversityEli Lilly & Company LtdOregon Health and Science University
Molecular mechanisms underlying divergent incretin receptor responses in alpha versus beta cellsActiveMRC · Research Grant · 2023-08-31 – 2026-08-30 · with 8 other participants£589,596whole project
Molecular mechanisms underlying divergent incretin receptor responses in alpha versus beta cellsActive
MRC · Research Grant · 2023-08-31 – 2026-08-30 · with 8 other participants
£589,596
whole project
Imperial College LondonleadCoventry UniversityEli Lilly and Company (International)Eli Lilly & Company LtdEuropean Centre for the Study of DiabeteKing'S College LondonRutherford Appleton LaboratoryUniversity Of OxfordUppsala University
Developing a mechanistic rationale for alpha-synuclein targeting therapies in Parkinson's diseaseActiveMRC · Fellowship · 2021-11-01 – 2027-06-29 · with 1 other participant£1,756,538whole project
Developing a mechanistic rationale for alpha-synuclein targeting therapies in Parkinson's diseaseActive
MRC · Fellowship · 2021-11-01 – 2027-06-29 · with 1 other participant
£1,756,538
whole project
University Of OxfordleadEli Lilly & Company Ltd
Made Smarter Innovation - Digital Medicines Manufacturing Research CentreISCF · Research Grant · 2021-09-29 – 2025-03-29 · with 50 other participants£5,086,406whole project
Made Smarter Innovation - Digital Medicines Manufacturing Research Centre
ISCF · Research Grant · 2021-09-29 – 2025-03-29 · with 50 other participants
£5,086,406
whole project
University Of StrathclydeleadAltair Engineering LtdApplied MaterialsAstrazenecaAstraZenecaBdd Pharma LtdBlaze Metrics, LLC.Calderdale & Huddersfield NHS Foun TrustCambridge Crystallographic Data CentreCancer Research UKCentre for Process InnovationCentre for Process Innovation (CPI)ChiesiChiesi PharmaceuticalsConnected Everything Network+ (II)CpactDietrich Engineering Consultants S.A.Eli Lilly & Company LtdEPSRC Future Manufact Hub Target HealthFette CompactingGlasgow School of ArtGlaxoSmithKline (GSK)GskHenry Royce InstituteKnowledge Transfer NetworkKnowledge Transfer Network LimitedKUKA RoboticsKUKA Robotics UK LimitedLoughborough UniversityMalvern PanalyticalMalvern Panalytical LtdMedelpharmMedicines and Healthcare Regulatory AgencyMg2 S.r.l.National Physical LaboratoryNvidiaNvidia Limited (UK)Perceptive Engineering LimitedPfizer Incroche pharmaceuticalsShionogi & Co., Ltd.Siemens Process Systems Engineering LtdSmith and NephewSmith and Nephew Medical LtdTakeda Pharmaceutical CompanyTuv Sud (UK)UCB PharmaUcb SAUniversity of CambridgeUniversity Of NottinghamUniversity of Strathclyde
Unravelling dorsal root ganglion as an intrinsic filtering deviceMRC · Research Grant · 2021-08-31 – 2024-12-31 · with 2 other participants£454,303whole project
Unravelling dorsal root ganglion as an intrinsic filtering device
MRC · Research Grant · 2021-08-31 – 2024-12-31 · with 2 other participants
£454,303
whole project
MICA ADVANTAGE visceral pain consortium: Advanced Discovery of Visceral Analgesics via Neuroimmune Targets and the Genetics of Extreme human phenotypeSPF · Research Grant · 2021-06-30 – 2026-06-29 · with 11 other participants£4,101,153whole project
MICA ADVANTAGE visceral pain consortium: Advanced Discovery of Visceral Analgesics via Neuroimmune Targets and the Genetics of Extreme human phenotype
SPF · Research Grant · 2021-06-30 – 2026-06-29 · with 11 other participants
£4,101,153
whole project
University Of CambridgeleadAstrazenecaAstraZenecaColumbia UniversityEli Lilly & Company LtdEli Lilly (United Kingdom)Rutgers UniversityThe Walton CentreUniversity Hospital WürzburgUniversity of IowaUniversity Of OxfordUniversity of Texas at Dallas
Regulation of plateau potentials by dendritically targeted inhibitory synaptic transmission.BBSRC · Research Grant · 2021-03-23 – 2024-03-22 · with 3 other participants£489,839whole project
Regulation of plateau potentials by dendritically targeted inhibitory synaptic transmission.
BBSRC · Research Grant · 2021-03-23 – 2024-03-22 · with 3 other participants
£489,839
whole project
MICA: Dementias Platform UK 2 - Integrated Dementia Experimental MedicineActiveMRC · Research Grant · 2021-01-01 – 2027-06-29 · with 62 other participants£13,635,487whole project
MICA: Dementias Platform UK 2 - Integrated Dementia Experimental MedicineActive
MRC · Research Grant · 2021-01-01 – 2027-06-29 · with 62 other participants
£13,635,487
whole project
University Of OxfordleadAlectorAlzheimer'S Research UKAlzheimers SocietyApellis PharmaceuticalAstraZenecaAutifony Therapeutics LimitedBoostecBrainDTech SpACambridge Cognition LtdCardiff UniversityCatalan Health Institute (ICS)Cognetivity LtdCytOx LimitedDanish Research Centre for Magnetic Resonance (DRCMR)Eisai LtdEli Lilly & Company LtdEli Lilly (United Kingdom)EMBL European Bioinformatics Institute (EMBL - EBI)European Bank for induced pluripotent Stem CellsFerrer InternacionalF. Hoffmann-La Roche AGFlame UniversityGates Ventures, LLC.German Centre for Neurodegenerative DiseasesGlobal Alzheimer's Platform FoundationGskHarvard UniversityIMI Europe LimitedIrish Critical Care Clinical Trials NetworkIXICO Technologies LtdJanssen Research & Development LLCKing'S College LondonLudwig Maximilian University of Munich (LMU Munich)Mayo ClinicMcGill UniversityMedical Research Council (MRC)National Institute for Health and Care ResearchNational Institutes of Health (NIH)Roche PharmaceuticalsRodin Therapeutics, Inc.Rush University Medical CenterSouth Kazakhstan Medical AcademyStanford UniversityThe Hong Kong University of Science and TechnologyUCB PharmaUniversity College CopenhagenUniversity College LondonUniversity of BristolUniversity of California, IrvineUniversity of California, San FranciscoUniversity of CambridgeUniversity Of EdinburghUniversity of GlasgowUniversity of GothenburgUniversity of LeuvenUniversity of LiegeUniversity of LilleUniversity Of ManchesterUniversity Of NottinghamUniversity of San FranciscoUniversity of TorontoVU University Medical Center
MICA: Exosomes and microRNAs regulate neuro-immune interactions in chronic painMRC · Research Grant · 2020-09-30 – 2024-08-18 · with 3 other participants£574,040whole project
MICA: Exosomes and microRNAs regulate neuro-immune interactions in chronic pain
MRC · Research Grant · 2020-09-30 – 2024-08-18 · with 3 other participants
£574,040
whole project
Dysregulated WNT signaling as a driver of motor neuron loss in Amyotrophic Lateral SclerosisMRC · Research Grant · 2020-08-14 – 2024-06-13 · with 7 other participants£483,438whole project
Dysregulated WNT signaling as a driver of motor neuron loss in Amyotrophic Lateral Sclerosis
MRC · Research Grant · 2020-08-14 – 2024-06-13 · with 7 other participants
£483,438
whole project
University Of ExeterleadAstrazenecaChinese University of Hong KongEli Lilly & Company LtdSapienza University of RomeUniversity of ExeterUniversity Of OxfordUniversity of Sheffield
Technological evaluation and commercial assessment of a novel technology platform for pharmacophore generationBBSRC · Research Grant · 2019-09-01 – 2020-03-01 · with 7 other participants£9,306whole project
Technological evaluation and commercial assessment of a novel technology platform for pharmacophore generation
BBSRC · Research Grant · 2019-09-01 – 2020-03-01 · with 7 other participants
£9,306
whole project
University of LeedsleadEli Lilly & Company LtdMedicines Discovery CatapultPharmEnable LimitedUniversity of CambridgeUniversity of GlasgowUniversity of PlymouthUniversity of Texas Health Science Center San Antonio, BrainMap Database
IPA: Anorectic signaling by the central GDF15/GFRAL systemBBSRC · Research Grant · 2019-05-14 – 2022-05-13 · with 2 other participants£467,315whole project
IPA: Anorectic signaling by the central GDF15/GFRAL system
BBSRC · Research Grant · 2019-05-14 – 2022-05-13 · with 2 other participants
£467,315
whole project
Characterisation of oligodendrocyte plasticity in the adult median eminence and its role in the regulation of energy balanceMRC · Research Grant · 2019-03-04 – 2022-07-02 · with 5 other participants£520,614whole project
Characterisation of oligodendrocyte plasticity in the adult median eminence and its role in the regulation of energy balance
MRC · Research Grant · 2019-03-04 – 2022-07-02 · with 5 other participants
£520,614
whole project
University Of CambridgeleadEli Lilly & Company LtdUniversity of CambridgeUniversity of Colorado DenverUniversity of WashingtonWayne State University
Accelerated Discovery and Development of New Medicines: Prosperity Partnership for a Healthier NationEPSRC · Research Grant · 2019-01-01 – 2024-09-29 · with 9 other participants£5,592,738whole project
Accelerated Discovery and Development of New Medicines: Prosperity Partnership for a Healthier Nation
EPSRC · Research Grant · 2019-01-01 – 2024-09-29 · with 9 other participants
£5,592,738
whole project
University Of StrathclydeleadAdded ScientificEli Lilly & Company LtdEngineering and Physical Sciences Research Council (EPSRC)GskImperial College LondonKey Organics LtdPerceptive Engineering LimitedStrem Chemicals UK LtdUniversity Of Nottingham
MICA: Childhood arthritis and its associated uveitis: stratification through endotypes and mechanism to deliver benefit; the CLUSTER Consortium.MRC · Research Grant · 2018-07-02 – 2024-07-02 · with 79 other participants£4,071,932whole project
MICA: Childhood arthritis and its associated uveitis: stratification through endotypes and mechanism to deliver benefit; the CLUSTER Consortium.
MRC · Research Grant · 2018-07-02 – 2024-07-02 · with 79 other participants
£4,071,932
whole project
University College LondonleadAbbVieAddenbrooke's HospitalAlder Hey Children'S NHS Foundation TrustArthritis UKARUK Centre for Adolescent RheumatologyBangor UniversityBarbara Ansell National Network (BANNAR)Birmingham Children's HospitalBritish Soc for Paed & Adol Rheum BSPARBritish Society for Paediatric and Adolescent Rheumatology (BSPAR)Capture Jia StudyCARRA (Child Arth & Rheum Res Alliance)Celltech Group plcCHARMS Study Parent RepresentativeChildrens Chronic Arthritis AssociationChildren's Hospital Los Angeles (CHLA)Children's Hospital of PhiladelphiaChildren's Mercy HospitalCincinnati Children's Hospital Medical CenterCincinnati Children's Hosp Res FoundCity St George's, University of LondonCity St George’s, University of LondonColorado Retina CenterEli Lilly & Company LtdFarr InstituteGreat North Children's Hospital (GNCH)Great Ormond St. Hospital Cldrn CharityGreat Ormond Street HospitalGreat Ormond Street Hospital for Children NHS Foundation TrustGreat Ormond Street Hospital (GOSH)GskICON/GPRD German JIA CohortsIMID-BIO-UK partnershipJohns Hopkins MedicineJohnson & JohnsonJuvenile Arthritis Research (JAR)King'S College LondonManchester UniversityMaturaMoorfields Eye Hospital NHS Foundation TrustMurdoch Children's Research InstituteNational Institutes of Health (NIH)National Rheumatoid Arthritis SocietyNorfolk And Norwich University HospitalNottingham University Hospitals NHS TrustOlivia's VisionPfizerPfizer IncPRCSG (Ped Rheum Collab Study Group)PReS (Paed Rheumatology European Soc)PrintoQueen Mary University of LondonRA-MAP ConsortiumRocheRoyal Children's Hospital MelbourneRoyal National HospitalRoyal Wolverhampton Hospitals NHS TrustSeattle Children's HospitalSheffield Children's NHS Foundation TrustUcan-UUcb SAUniversity Children's Hospital MunsterUniversity College LondonUniversity College London Hospitals NHS Foundation TrustUniversity Hospitals Bristol NHS Foundation TrustUniversity Hospital Southampton NHS Foundation TrustUniversity Of BirminghamUniversity of BristolUniversity of California, San FranciscoUniversity of CambridgeUniversity of LeedsUniversity of LiverpoolUniversity Of ManchesterUniversity of Muenster (Munster)University Of OxfordUniversity of TorontoUniversity of Utah Health CareUtrecht UniversityYour Rheum
MICA: Sensory plasticity and adaptation in neurodegenerationMRC · Research Grant · 2018-05-31 – 2021-09-29 · with 4 other participants£679,595whole project
MICA: Sensory plasticity and adaptation in neurodegeneration
MRC · Research Grant · 2018-05-31 – 2021-09-29 · with 4 other participants
£679,595
whole project
University College LondonleadEli Lilly & Company LtdEli Lilly (United Kingdom)Radboud University NijmegenUniversity College London
Targeting GLP-1 receptor trafficking to improve therapies for type 2 diabetesMRC · Research Grant · 2018-03-16 – 2021-03-15 · with 21 other participants£561,774whole project
Targeting GLP-1 receptor trafficking to improve therapies for type 2 diabetes
MRC · Research Grant · 2018-03-16 – 2021-03-15 · with 21 other participants
£561,774
whole project
Imperial College LondonleadAstrazenecaCouncil of Scientific and Industrial Research (CSIR)Coventry UniversityDuke UniversityEli Lilly & Company LtdImmuPharmaImperial College Healthcare NHS TrustKarolinska InstituteKing'S College LondonMonash UniversityRutherford Appleton LaboratoryThe CNR Institute of Neuroscience, Padova, ItalyUniversity College LondonUniversity of AlbertaUniversity Of BirminghamUniversity of BordeauxUniversity Of EssexUniversity of GenevaUniversity Of OxfordUniversity of PisaUppsala University
Neural adaptation to sensory stimuli by regulation of dendritic spikes and synaptic plasticity.BBSRC · Research Grant · 2018-01-01 – 2022-06-29 · with 2 other participants£885,716whole project
Neural adaptation to sensory stimuli by regulation of dendritic spikes and synaptic plasticity.
BBSRC · Research Grant · 2018-01-01 – 2022-06-29 · with 2 other participants
£885,716
whole project
Regulatory genomic profiling in schizophreniaMRC · Research Grant · 2018-01-01 – 2023-04-29 · with 13 other participants£1,028,262whole project
Regulatory genomic profiling in schizophrenia
MRC · Research Grant · 2018-01-01 – 2023-04-29 · with 13 other participants
£1,028,262
whole project
University Of ExeterleadAarhus UniversityCambridge EpigenetixDuke UniversityEli Lilly & Company LtdIcahn School of Medicine at Mount SinaiPrinceton UniversityUK BiobankUniversity College LondonUniversity of CambridgeUniversity Of EdinburghUniversity of EssexUniversity of ExeterUniversity of Virginia Medical Center
Targeting the M4 muscarinic acetylcholine receptor in neurodegenerative diseaseMRC · Studentship · 2017-10-01 – 2022-03-30 · with 2 other participants£0whole project
Targeting the M4 muscarinic acetylcholine receptor in neurodegenerative disease
MRC · Studentship · 2017-10-01 – 2022-03-30 · with 2 other participants
£0
whole project
University of GlasgowleadEli Lilly & Company LtdEli Lilly (United Kingdom)
Genetic interrogation of central circuit regulating blood pressureBBSRC · Research Grant · 2017-10-01 – 2020-09-30 · with 2 other participants£478,588whole project
Genetic interrogation of central circuit regulating blood pressure
BBSRC · Research Grant · 2017-10-01 – 2020-09-30 · with 2 other participants
£478,588
whole project
Genomic characterisation of Alzheimer's disease risk genes using long-read sequencingCOVID · Studentship · 2017-09-30 – 2022-04-02 · with 4 other participants£0whole project
Genomic characterisation of Alzheimer's disease risk genes using long-read sequencing
COVID · Studentship · 2017-09-30 – 2022-04-02 · with 4 other participants
£0
whole project
University Of ExeterleadEli Lilly & Company LtdEli Lilly (United Kingdom)Icahn School of Medicine at Mount SinaiPacific Biosciences of California, Inc.
Functional expression of M channel subunits in peripheral somatosensory systemMRC · Studentship · 2017-09-30 – 2021-09-29 · with 2 other participants£0whole project
Functional expression of M channel subunits in peripheral somatosensory system
MRC · Studentship · 2017-09-30 – 2021-09-29 · with 2 other participants
£0
whole project
Distinct forebrain system regulating arousalBBSRC · Research Grant · 2017-09-30 – 2020-09-29 · with 2 other participants£489,811whole project
Distinct forebrain system regulating arousal
BBSRC · Research Grant · 2017-09-30 – 2020-09-29 · with 2 other participants
£489,811
whole project
MICA: Un-jamming the Ras switch - blocking Ras nucleotide exchange and promoting GTP hydrolysisMRC · Research Grant · 2017-09-30 – 2022-05-30 · with 8 other participants£588,633whole project
MICA: Un-jamming the Ras switch - blocking Ras nucleotide exchange and promoting GTP hydrolysis
MRC · Research Grant · 2017-09-30 – 2022-05-30 · with 8 other participants
£588,633
whole project
University of LeedsleadAvacta Group PLCEli Lilly & Company LtdMedicines Discovery CatapultPharmEnable LimitedUniversity of CambridgeUniversity of GlasgowUniversity of PlymouthUniversity of Texas Health Science Center San Antonio, BrainMap Database
MICA Pharmacological, molecular and cellular mechanisms of muscarinic slowing (modification) of neurodegenerative disease.MRC · Research Grant · 2017-09-30 – 2022-03-30 · with 1 other participant£1,058,862whole project
MICA Pharmacological, molecular and cellular mechanisms of muscarinic slowing (modification) of neurodegenerative disease.
MRC · Research Grant · 2017-09-30 – 2022-03-30 · with 1 other participant
£1,058,862
whole project
University of GlasgowleadEli Lilly & Company Ltd
Signalling mechanisms that determine the rate of ageingBBSRC · Institute Project · 2017-03-31 – 2024-03-31 · with 21 other participants£6,126,087whole project
Signalling mechanisms that determine the rate of ageing
BBSRC · Institute Project · 2017-03-31 – 2024-03-31 · with 21 other participants
£6,126,087
whole project
Babraham InstituteleadAgricultural University of Athens (AUA)AstraZenecaCardiff UniversityCold Spring Harbor Laboratory (CSHL)Eli Lilly & Company LtdFrancis Crick InstituteMarche Polytechnic UniversityMax Planck SocietyPhoremostRoyal Veterinary College (RVC)Takeda Cambridge LtdUniversity College CorkUniversity College LondonUniversity of BonnUniversity Of CambridgeUniversity Of DundeeUniversity Of EdinburghUniversity of LeedsUniversity Of LiverpoolVernalisWellcome Sanger Institute
Calibration of multiple treatment comparisons using individual patient dataMRC · Research Grant · 2017-03-01 – 2020-02-29 · with 5 other participants£313,484whole project
Calibration of multiple treatment comparisons using individual patient data
MRC · Research Grant · 2017-03-01 – 2020-02-29 · with 5 other participants
£313,484
whole project
University of BristolleadEli Lilly & Company LtdNational Institute for Health and Care Excellence (NICE)University of LiverpoolUniversity of Murcia, SpainUniversity of Sheffield
Photo-Electro: Transforming Chemical Synthesis, Discovery and ManufactureEPSRC · Research Grant · 2017-02-06 – 2023-08-04 · with 43 other participants£6,486,389whole project
Photo-Electro: Transforming Chemical Synthesis, Discovery and Manufacture
EPSRC · Research Grant · 2017-02-06 – 2023-08-04 · with 43 other participants
£6,486,389
whole project
University Of NottinghamleadAnsys, IncANSYS (International)ArcinovaArc Trinova Ltd (Arcinova)AstrazenecaAstraZenecaAsyntAsynt LtdBeta Technology LtdBritestBritest LimitedCambridge Reactor DesignCambridge Reactor Design LtdCentre for Process InnovationCentre for Process Innovation (CPI)Eli Lilly and Company (International)Eli Lilly & Company LtdEnlumo LtdGivaudanGivaudan (International)GlaxoSmithKline (GSK)GskHel GroupHEL LimitedHuvepharmaJohnson MattheyKnowledge Transfer NetworkKnowledge Transfer Network LimitedMerckMerck Chemicals Ltd UKMettler-Toledo Auto ChemNovartisNovartis Pharma AGSanofiSanofiAventis Deutschland GmbHSiemens Process Systems Engineering LtdSyngentaSyngenta International AGThomas Swan and Co LtdThomas Swan & Co LimitedUnileverUnilever UK Central Resources LimitedUniqsis Ltd
Sustainable Electron-Transfer Processes for the Synthesis and Functionalization of Nitrogen-Containing CompoundsEPSRC · Fellowship · 2017-02-01 – 2022-01-31 · with 3 other participants£942,832whole project
Sustainable Electron-Transfer Processes for the Synthesis and Functionalization of Nitrogen-Containing Compounds
EPSRC · Fellowship · 2017-02-01 – 2022-01-31 · with 3 other participants
£942,832
whole project
Future Targeted Healthcare Manufacturing HubEPSRC · Research Grant · 2017-01-01 – 2024-12-31 · with 90 other participants£10,851,089whole project
Future Targeted Healthcare Manufacturing Hub
EPSRC · Research Grant · 2017-01-01 – 2024-12-31 · with 90 other participants
£10,851,089
whole project
University College Londonlead3MAdaptimmuneAglaris LtdAlbumedix LtdAlbumedix LtdAllerganAllergan Limited (UK)Applikon Biotechnology B.V.Association of the British Pharmaceutical IndustryAssoc of the British Pharm Ind (ABPI)AstrazenecaAstraZenecaAutolusAutolus LimitedAutolus LtdBIA SeparationsBioindustry AssociationBioLogicB LLCBioLogicB, LLCBiopharm ServicesBiopharm Services LimitedCancer Research UKCell And Gene Therapy CatapultCell Medica Ltd.Celltech Group plcCell Therapy CatapultCentre for Process InnovationCentre for Process Innovation (CPI)CSL BehringdeltaDOT LtdEli Lilly & Company LtdEli Lilly S.A. - Irish BranchFloDesign SonicsFrancis BiopharmaFrancis Biopharma LtdFujifilmFujifilm UK LtdGlaxoSmithKline (GSK)GskImperial College LondonIpsenIrvine ScientificKnowledge Transfer NetworkKnowledge Transfer Network LimitedKuopio Center for Gene and Cell TherapyLaboratory of the Government Chemist (LGC) LtdLgcLgc LtdLonza Biologics PLCLonza GroupMedicines & Healthcare pdts Reg Acy MHRAMedicines Manufacturing Ind PartnershipMedicines Manufacturing Industry PartnershipMerck KGaAMerck Sharpe and DohmeNational Institute for Biological Standards and Control (NIBSC)Novo Nordisk A/SOrchard TherapeuticsOvizio Imaging Systems NV SAOxford BioMedica UK LtdOxford BioMedica (United Kingdom)Pall EuropePerceptive Engineering LimitedPerceptive Engineering LtdPfizerPharmaronPuridifyPuridify LTDPurolite International LtdRedbud LabsReneuronReneuron LtdRepligenRoche Diagnostics GmbHSartoriusSartorius Stedim UK LimitedShanghai Pulmonary HospitalSsc BioSutro BiopharmaTillingbourne Consulting LimitedTrakCelUcb SAUK BioIndustry Association (BIA)United Kingdom Research and InnovationUnivercells LtdUniversity College LondonUniversity of WarwickWest Pharmaceutical ServicesWyatt Technology CorporationWyatt Technology UK Ltd
Future Continuous Manufacturing and Advanced Crystallisation Research HubEPSRC · Research Grant · 2017-01-01 – 2024-09-29 · with 63 other participants£10,864,793whole project
Future Continuous Manufacturing and Advanced Crystallisation Research Hub
EPSRC · Research Grant · 2017-01-01 – 2024-09-29 · with 63 other participants
£10,864,793
whole project
University Of StrathclydeleadAB Sugar (British Sugar Group)Alconbury Weston LtdAltair Engineering LtdAM TechnologyAnalytik LtdAnatuneAstrazenecaAstraZenecaBayerBayer Pharma AGBlacktrace Holdings LimitedBlacktrace Holdings LtdBooth WelshBritestBritest LimitedBüchi LabortechnikCambridge Crystallographic Data CentreCambridge Reactor Design LtdCancer Research UKCentre for Process InnovationChiesiClairet ScientificClairet Scientific LtdCroda Europe LimitedDEM Solutions LimitedDiamond Light SourceDr Reddy's Laboratories UK LtdEli Lilly & Company LtdEncap Drug DeliveryFUJIFILM Imaging colorants LimitedGlaxoSmithKline (GSK)GskHovione (International)Infineum UK LtdKnowledge Transfer Network LimitedMalvern Instruments LtdMars Chocolate UK LtdMerck Sharpe and DohmeMettler-Toledo AutoChem, Inc.M-Star Simulations LLCNational Physical LaboratoryNiTech Solutions LtdNovartisPerceptive Engineering LimitedPerceptive Engineering LtdPfizer IncPrice Waterhouse CooperPrice Waterhouse Coopers LLPRobinson Brothers LtdRoche PharmaceuticalsSiemens AGSiemens plc (UK)Siemens Process Systems Engineering LtdSirius Analytical Instrumentation LtdSolid Form SolutionsSyngentaSyrius Analytical Instruments LtdTakeda Pharmaceutical CompanyTakeda Pharmaceutical International Co,Technobis Crystallization SystemsUCB PharmaUcb SAUniversity of Strathclyde
Contributions of prefrontal-midbrain-spinal cord network dynamics to the development and maintenance of chronic neuropathic pain.MRC · Research Grant · 2017-01-01 – 2019-12-30 · with 1 other participant£395,448whole project
Contributions of prefrontal-midbrain-spinal cord network dynamics to the development and maintenance of chronic neuropathic pain.
MRC · Research Grant · 2017-01-01 – 2019-12-30 · with 1 other participant
£395,448
whole project
University of BristolleadEli Lilly & Company Ltd
Non-Invasive Imaging of Glymphatic Clearance: A Novel Strategy for the Early Diagnosis of Alzheimer's DiseaseEPSRC · Research Grant · 2016-11-01 – 2019-01-31 · with 3 other participants£304,371whole project
Non-Invasive Imaging of Glymphatic Clearance: A Novel Strategy for the Early Diagnosis of Alzheimer's Disease
EPSRC · Research Grant · 2016-11-01 – 2019-01-31 · with 3 other participants
£304,371
whole project
University College LondonleadEli Lilly & Company LtdEli Lilly (United Kingdom)University College London
TRP channel control of pain and analgesiaMRC · Studentship · 2016-09-30 – 2021-03-29 · with 1 other participant£0whole project
TRP channel control of pain and analgesia
MRC · Studentship · 2016-09-30 – 2021-03-29 · with 1 other participant
£0
whole project
King'S College LondonleadEli Lilly & Company Ltd
Plasticity of inhibitory synaptic transmission in the hippocampusBBSRC · Research Grant · 2016-09-30 – 2019-09-29 · with 2 other participants£571,227whole project
Plasticity of inhibitory synaptic transmission in the hippocampus
BBSRC · Research Grant · 2016-09-30 – 2019-09-29 · with 2 other participants
£571,227
whole project
Reward networks and appetitive behaviourBBSRC · Research Grant · 2016-03-31 – 2019-03-31 · with 1 other participant£452,137whole project
Reward networks and appetitive behaviour
BBSRC · Research Grant · 2016-03-31 – 2019-03-31 · with 1 other participant
£452,137
whole project
University Of ManchesterleadEli Lilly & Company Ltd
MICA: A UK-wide networking partnership to facilitate collaborative research in the idiopathic inflammatory myopathiesMRC · Research Grant · 2016-01-04 – 2020-01-03 · with 15 other participants£808,084whole project
MICA: A UK-wide networking partnership to facilitate collaborative research in the idiopathic inflammatory myopathies
MRC · Research Grant · 2016-01-04 – 2020-01-03 · with 15 other participants
£808,084
whole project
University Of ManchesterleadAlder Hey Children'S NHS Foundation TrustAstrazenecaChildhood Arthritis and Rheumatology Research Alliance (CARRA)Eli Lilly & Company LtdEuropean CommissionGreat Ormond Street Hospital (GOSH)ImaxioKings Health PartnersMyoNetPediatric Rheumatology INternational Trials Organisation (PRINTO)UCL PartnersUK MyoNetUniversity College LondonUniversity of BathUniversity of Liverpool
Manchester Molecular Pathology Innovation Centre (MMPathIC): bridging the gap between biomarker discovery and health and wealthMRC · Research Grant · 2015-09-30 – 2021-03-30 · with 17 other participants£2,923,764whole project
Manchester Molecular Pathology Innovation Centre (MMPathIC): bridging the gap between biomarker discovery and health and wealth
MRC · Research Grant · 2015-09-30 – 2021-03-30 · with 17 other participants
£2,923,764
whole project
University Of ManchesterleadAPIS Assay TechnologiesAptamer GroupBristol-Myers SquibbEli Lilly & Company LtdKurma PartnersMdsasMicromass UK Ltd (Waters Corporation)Newcastle UniversityQiagenQiagen UKSciexShanghai Jiao Tong UniversitySienna Cancer DiagnosticsSingulex, Inc.Thermo Fisher Scientific UKUniversity of GranadaUniversity of Leeds
UK Dementias PlatformMRC · Research Grant · 2015-08-31 – 2023-07-30 · with 84 other participants£15,256,623whole project
UK Dementias Platform
MRC · Research Grant · 2015-08-31 – 2023-07-30 · with 84 other participants
£15,256,623
whole project
University Of OxfordleadAlan Turing InstituteAlectorAlzheimer's Disease Neuroimaging InitiativeAlzheimer's Research UKAmyloid Imaging to Prevent Alzheimer's DiseaseApellis PharmaceuticalAraclon BiotechAstrazenecaBarcelona Beta Brain Research CenterBoostecBristol-Myers SquibbCardiff UniversityCatalan Health Institute (ICS)Danish Research Centre for Magnetic Resonance (DRCMR)Eisai LtdEli Lilly & Company LtdEMBL European Bioinformatics Institute (EMBL - EBI)ETH ZurichEU Joint Programme - Neurodegenerative Disease Research (JPND)European Medical Information Framework (EMIF)Ferrer InternacionalFlame UniversityGerman Centre for Neurodegenerative DiseasesGlaxoSmithKline (GSK)Government of WalesHarvard UniversityImperial College LondonIRCCS Policlinico San DonatoIrish Critical Care Clinical Trials NetworkIxicoJanssen Biotech, Inc.Janssen Research & DevelopmentJohnson & JohnsonKing'S College LondonLife Molecular ImagingLudwig Maximilian University of Munich (LMU Munich)McGill UniversityMedical Research Council (MRC)MRC Dementias Platform UKNational Institute on AgingNational Institutes of Health (NIH)Newcastle UniversityObservational Health Data Sciences and InformaticsOxford University Hospitals NHS Foundation TrustPolytechnic University of MilanProgressive Supranuclear Palsy Association (PSPA)Rush University Medical CenterSomaLogicStanford UniversitySwansea UniversityThe Hong Kong University of Science and TechnologyThe International Parkinson Disease Genomics ConsortiumUK Dementia Research InstituteUniversity College CopenhagenUniversity College LondonUniversity of BarcelonaUniversity of BolognaUniversity of BristolUniversity of California, IrvineUniversity of California, San FranciscoUniversity of CambridgeUniversity Of East AngliaUniversity Of EdinburghUniversity of ExeterUniversity of GlasgowUniversity of GothenburgUniversity of GöttingenUniversity of LeuvenUniversity of LiegeUniversity of LilleUniversity of LiverpoolUniversity of LuxembourgUniversity Of ManchesterUniversity of MilanUniversity Of NottinghamUniversity of OsloUniversity of San FranciscoUniversity of Southern CaliforniaUniversity of Southern DenmarkUniversity of TorontoVU University Medical CenterWashington University in St LouisWAVE Life SciencesWellcome Trust
MICA: MRC APBI STratification and Extreme Response Mechanism IN Diabetes - MASTERMINDMRC · Research Grant · 2015-07-31 – 2021-12-31 · with 11 other participants£3,406,382whole project
MICA: MRC APBI STratification and Extreme Response Mechanism IN Diabetes - MASTERMIND
MRC · Research Grant · 2015-07-31 – 2021-12-31 · with 11 other participants
£3,406,382
whole project
University Of ExeterleadAlan Turing InstituteAstrazenecaEli Lilly & Company LtdGlaxoSmithKline (GSK)King'S College LondonSanofiTakeda Pharmaceutical CompanyUniversity of DundeeUniversity of GlasgowUniversity Of NewcastleUniversity Of Oxford
MAximizing Sle ThERapeutic PotentiaL by Application of Novel and Stratified approaches (MASTERPLANS)MRC · Research Grant · 2015-06-14 – 2021-02-28 · with 37 other participants£4,185,920whole project
MAximizing Sle ThERapeutic PotentiaL by Application of Novel and Stratified approaches (MASTERPLANS)
MRC · Research Grant · 2015-06-14 – 2021-02-28 · with 37 other participants
£4,185,920
whole project
University Of ManchesterleadAeirtecAeirtec LimitedAstrazenecaAstraZenecaAurinia Pharmaceuticals IncBristol-Myers SquibbEli Lilly & Company LtdEpistemEpistem LimitedGenentech IncGenentech, IncGlaxoSmithKline (Global)GlaxoSmithKline (GSK)Imagen BiotechImagen Biotech LtdImperial College LondonJohnson & JohnsonKing'S College LondonLupus Foundation of AmericaMedical Research Council (MRC)Myriad RBM IncMyriad RBM USANewcastle UniversityPfizer IncShanghai Jiao Tong UniversityThe European League Against Rheumatism (EULAR)UCB PharmaUcb SAUniversity College LondonUniversity of BathUniversity Of BirminghamUniversity of CambridgeUniversity of GranadaUniversity of LeedsUniversity of LiverpoolUniversity of TampereUniversity of Warwick
Accelerated discovery of functional non-coding genomic variation using single molecule real-time (SMRT) sequencing.MRC · Research Grant · 2015-03-31 – 2016-03-30 · with 14 other participants£50,000whole project
Accelerated discovery of functional non-coding genomic variation using single molecule real-time (SMRT) sequencing.
MRC · Research Grant · 2015-03-31 – 2016-03-30 · with 14 other participants
£50,000
whole project
University Of ExeterleadAarhus UniversityCambridge EpigenetixEli Lilly & Company LtdIcahn School of Medicine at Mount SinaiKing'S College LondonPrinceton UniversityTwist BioscienceUK BiobankUniversity College LondonUniversity of CambridgeUniversity Of EdinburghUniversity of EssexUniversity of ExeterUniversity of Virginia Medical Center
Innovative Technologies for Stratified and Experimental MedicineMRC · Research Grant · 2015-03-31 – 2016-03-30 · with 16 other participants£14,621,436whole project
Innovative Technologies for Stratified and Experimental Medicine
MRC · Research Grant · 2015-03-31 – 2016-03-30 · with 16 other participants
£14,621,436
whole project
University Of CambridgeleadEli Lilly & Company LtdGE Healthcare LimitedImperial College LondonLgc LtdLudwig Maximilian University of Munich (LMU Munich)Mercodia ABMotilent LtdSiemens AGSiemens HealthcareUniversity of AdelaideUniversity of BaselUniversity of California, San FranciscoUniversity of CambridgeUniversity Of EdinburghUniversity Of NottinghamUniversity of Warwick
MICA: Psoriasis Stratification to Optimise Relevant Therapy (PSORT)MRC · Research Grant · 2014-08-31 – 2021-05-30 · with 32 other participants£5,054,543whole project
MICA: Psoriasis Stratification to Optimise Relevant Therapy (PSORT)
MRC · Research Grant · 2014-08-31 – 2021-05-30 · with 32 other participants
£5,054,543
whole project
University Of ManchesterleadAbbvieAbbVie IncAstrazenecaAstraZenecaBecton Dickinson and CompanyBecton, Dickinson and CompanyBristol-Myers SquibbBritish Association of Dermatologists (BAD)Celgene LimitedEli Lilly & Company LtdGlaxoSmithKline (GSK)GskGuy's and St Thomas' NHS Foundation TrustJanssen Pharmaceutica NVJohnson & JohnsonKing'S College LondonLEO PharmaNewcastle UniversityNHS Greater Glasgow and Clyde (NHSGGC)NovartisNovartis Pharmaceuticals UK LtdPfizerPfizer IncQiagenQiagen UKQueen Mary University of LondonRoyal College of Physicians of LondonSanquinSanquin Blood Supply FoundationThe Psoriasis AssociationUniversity College LondonUniversity of Liverpool
A thermogenic circuit that maintains sensitivity to leptin in obesityBBSRC · Research Grant · 2014-08-25 – 2017-08-24 · with 3 other participants£423,382whole project
A thermogenic circuit that maintains sensitivity to leptin in obesity
BBSRC · Research Grant · 2014-08-25 – 2017-08-24 · with 3 other participants
£423,382
whole project
UK Dementias PlatformMRC · Research Grant · 2014-06-29 – 2015-08-30 · with 34 other participants£13,148,876whole project
UK Dementias Platform
MRC · Research Grant · 2014-06-29 – 2015-08-30 · with 34 other participants
£13,148,876
whole project
Cardiff UniversityleadAlan Turing InstituteAlzheimer's Research UKAmyloid Imaging to Prevent Alzheimer's DiseaseAraclon BiotechAstrazenecaCardiff UniversityCatalan Health Institute (ICS)Eli Lilly & Company LtdEMBL European Bioinformatics Institute (EMBL - EBI)GlaxoSmithKline (GSK)Imperial College LondonIxicoJanssen Biotech, Inc.Janssen Research & DevelopmentKing'S College LondonMedical Research Council (MRC)MRC Dementias Platform UKNational Institutes of Health (NIH)Newcastle UniversitySomaLogicThe International Parkinson Disease Genomics ConsortiumUniversity College LondonUniversity of BristolUniversity of CambridgeUniversity Of EdinburghUniversity of ExeterUniversity of GlasgowUniversity of LiegeUniversity of LuxembourgUniversity Of ManchesterUniversity of OsloUniversity Of OxfordUniversity of PortoWellcome Trust
Centre for Drug Safety Science (CDSS)MRC · Research Grant · 2014-03-01 – 2022-12-31 · with 54 other participants£3,072,999whole project
Centre for Drug Safety Science (CDSS)
MRC · Research Grant · 2014-03-01 – 2022-12-31 · with 54 other participants
£3,072,999
whole project
University of LiverpoolleadAcademy of FinlandAllecra Therapeutics SASAmgen IncAndalusian Health ServiceASLAN PharmaceuticalsAstex PharmaceuticalsAstrazenecaBio.logis Genetic Information Management GMBHDiabetes UKEli Lilly & Company LtdF. Hoffmann-La Roche AGGemini Biosciences Ltd.GlaxoSmithKline (GSK)Illumina Inc.Imperial College LondonKarolinska InstituteKNMP Holding B.V.Leiden University Medical CenterLgc LtdLiverpool Health PartnersLiverpool Heart And Chest Hospital NHS Foundation TrustMC DiagnosticsMcLaren Applied TechnologiesMedical Research Council (MRC)Medical University of ViennaMedicines for Malaria Venture (MMV)MerckNewcastle UniversityNovartisNovartis Institutes for BioMedical Research (NIBR)Oncological Referral CentreOtsuka PharmaceuticalPaul Sabatier University (University of Toulouse III)Pfizer IncRobert Bosch FoundationRoyal Brompton & Harefield NHS Foundation TrustRoyal Liverpool and Broadgreen University Hospitals NHS TrustRoyal Liverpool University HospitalSengenicsSt Antonius HospitalSysmex CorporationThe Federal Institute for Drugs and Medical DevicesThe Golden Helix FoundationUcb SAUniversity College LondonUniversity Of BirminghamUniversity of British ColumbiaUniversity of CambridgeUniversity of LeicesterUniversity of LjubljanaUniversity Of ManchesterUniversity Of OxfordUniversity of PatrasUppsala University
MICA: Training and Novel Probes Programme in PET Neurochemistry - PET CallMRC · Research Grant · 2013-12-01 – 2018-11-30 · with 14 other participants£1,016,891whole project
MICA: Training and Novel Probes Programme in PET Neurochemistry - PET Call
MRC · Research Grant · 2013-12-01 – 2018-11-30 · with 14 other participants
£1,016,891
whole project
University Of CambridgeleadAltos LabsAXON Neuroscience SEEli Lilly & Company LtdFudan UniversityGE HealthcareGE Healthcare Life SciencesGE Healthcare LimitedGeneral ElectricHeinrich Heine University DüsseldorfKing'S College LondonMerck Sharpe and DohmeNational Institute of HealthNational Institutes of Health (NIH)University of Michigan
iPROBE: in-vivo Platform for the Real-time Observation of Brain Extracellular activityEPSRC · Research Grant · 2013-08-31 – 2016-08-30 · with 5 other participants£265,156whole project
iPROBE: in-vivo Platform for the Real-time Observation of Brain Extracellular activity
EPSRC · Research Grant · 2013-08-31 – 2016-08-30 · with 5 other participants
£265,156
whole project
University College LondonleadAxona LtdEli Lilly & Company LtdHoward Hughes Medical InstituteNew York UniversityUniversity College London
Methylomic profiling in schizophrenia: towards an integrated genetic-epigenetic approachMRC · Research Grant · 2013-08-30 – 2016-08-29 · with 12 other participants£835,855whole project
Methylomic profiling in schizophrenia: towards an integrated genetic-epigenetic approach
MRC · Research Grant · 2013-08-30 – 2016-08-29 · with 12 other participants
£835,855
whole project
University Of ExeterleadAarhus UniversityDuke UniversityEli Lilly & Company LtdIcahn School of Medicine at Mount SinaiKarolinska University HospitalKing'S College LondonPrinceton UniversityUK BiobankUniversity of BristolUniversity of CambridgeUniversity Of EdinburghUniversity of Essex
Further defining the genetic architecture of Alzheimer's diseaseMRC · Research Grant · 2013-08-28 – 2019-01-31 · with 66 other participants£2,739,222whole project
Further defining the genetic architecture of Alzheimer's disease
MRC · Research Grant · 2013-08-28 – 2019-01-31 · with 66 other participants
£2,739,222
whole project
Cardiff UniversityleadAlbert Ludwig University of FreiburgArizona Association for Play TherapyAutonomous University of MadridBangor UniversityBoston UniversityBrigham Young UniversityCardiff UniversityCentral Institute for Mental HealthDepartment of Health Social Services and Public Safety (DHSSPS)Eisai LtdEli Lilly & Company LtdErasmus MCFondazione Santa LuciaFree University of BerlinFriedrich-Alexander University Erlangen-NurembergGenetic and Environmental Risk in Alzheimer's Disease (GERAD)Genetic Architecture of Rate of Alzheimer’s Decline (GENAROAD) ConsortiumGenomics EnglandGerman Centre for Neurodegenerative DiseasesGlaxoSmithKline (GSK)Goethe University FrankfurtGuangdong Medical CollegeHelmholtz Association of German Research CentresHospital de Sant PauImperial College LondonJPND ResearchKing'S College LondonLudwig Maximilian University of Munich (LMU Munich)Mayo Foundation for Medical Education and Research (MFMER)Medical Research Council (MRC)National Center for Biotechnology Information (NCBI)National Institute of Health and Medical Research (INSERM)National Institutes of Health (NIH)Neuroscience; IOPNewcastle UniversityOxford University Hospitals NHS Foundation TrustPasteur Institute, LillePopulation Genetics Technologies LtdQueen's University BelfastQuest DiagnosticsSaarland UniversitySevernside Alliance for Translational Research (SARTRE)Swansea UniversityThe Jackson LaboratoryTrinity College DublinUniversity College LondonUniversity Duisburg-EssenUniversity of BonnUniversity of BristolUniversity of CambridgeUniversity of CantabriaUniversity of ExeterUniversity of HamburgUniversity of LilleUniversity Of ManchesterUniversity of NavarraUniversity Of NottinghamUniversity of OviedoUniversity Of OxfordUniversity of PennsylvaniaUniversity of SouthamptonUniversity of WashingtonUniversity of ZurichVU University Medical CenterWashington University in St LouisWellcome Sanger Institute
A platform for high throughput two-photon-targeted in vivo cellular physiologyBBSRC · Research Grant · 2013-08-25 – 2016-08-24 · with 3 other participants£417,868whole project
A platform for high throughput two-photon-targeted in vivo cellular physiology
BBSRC · Research Grant · 2013-08-25 – 2016-08-24 · with 3 other participants
£417,868
whole project
Molecular mechanisms of long-term Depression in the hippocampusMRC · Research Grant · 2013-04-30 – 2018-04-29 · with 3 other participants£1,940,651whole project
Molecular mechanisms of long-term Depression in the hippocampus
MRC · Research Grant · 2013-04-30 – 2018-04-29 · with 3 other participants
£1,940,651
whole project
University of BristolleadEli Lilly & Company LtdSeoul National UniversityUniversity of Nebraska-Lincoln
Keeping track of things: Forming associations between temporally separated eventsBBSRC · Research Grant · 2013-03-15 – 2016-04-06 · with 2 other participants£417,599whole project
Keeping track of things: Forming associations between temporally separated events
BBSRC · Research Grant · 2013-03-15 – 2016-04-06 · with 2 other participants
£417,599
whole project
University Of NottinghamleadEli Lilly & Company LtdLaboratory Animals in the Social Sciences and Humanities
MRC APBI STratification and Extreme Response Mechanism IN Diabetes - MASTERMINDMRC · Research Grant · 2013-02-25 – 2016-06-29 · with 10 other participants£2,733,604whole project
MRC APBI STratification and Extreme Response Mechanism IN Diabetes - MASTERMIND
MRC · Research Grant · 2013-02-25 – 2016-06-29 · with 10 other participants
£2,733,604
whole project
University Of ExeterleadAstrazenecaEli Lilly & Company LtdGlaxoSmithKline (GSK)King'S College LondonSanofiTakeda Pharmaceutical CompanyUniversity of DundeeUniversity of GlasgowUniversity of NewcastleUniversity Of Oxford
Template neuronal networks in developing neocortexMRC · Research Grant · 2013-01-03 – 2016-05-01 · with 3 other participants£470,870whole project
Template neuronal networks in developing neocortex
MRC · Research Grant · 2013-01-03 – 2016-05-01 · with 3 other participants
£470,870
whole project
Automated assessment of broiler chicken welfare using optical flow patterns in relation to behaviour, disease risk, environment and production.BBSRC · Research Grant · 2013-01-01 – 2016-06-29 · with 15 other participants£750,755whole project
Automated assessment of broiler chicken welfare using optical flow patterns in relation to behaviour, disease risk, environment and production.
BBSRC · Research Grant · 2013-01-01 – 2016-06-29 · with 15 other participants
£750,755
whole project
University Of OxfordleadAarhus UniversityAgri-cctv LtdCobb EuropeDuPontEli Lilly & Company LtdFrench National Institute of Agricultural ResearchGottfried Wilhelm Leibniz Universität HannoverHebrew University of JerusalemImperial College LondonLohmann Animal HealthMunters LtdNewcastle UniversityTyson FoodsUniversity of BernUniversity of Liege
GPR103 has multi-tissue effects on health and metabolismBBSRC · Research Grant · 2012-09-30 – 2015-09-29 · with 2 other participants£421,785whole project
GPR103 has multi-tissue effects on health and metabolism
BBSRC · Research Grant · 2012-09-30 – 2015-09-29 · with 2 other participants
£421,785
whole project
Regulation of spine Ca2+ dynamics and spike timing-dependent synaptic plasticity by muscarinic acetylcholine receptorsBBSRC · Research Grant · 2012-09-30 – 2015-09-29 · with 5 other participants£367,226whole project
Regulation of spine Ca2+ dynamics and spike timing-dependent synaptic plasticity by muscarinic acetylcholine receptors
BBSRC · Research Grant · 2012-09-30 – 2015-09-29 · with 5 other participants
£367,226
whole project
University of BristolleadEli Lilly & Company LtdImperial College LondonMaynooth UniversityOregon Health and Science UniversityUniversity of Exeter
KLF14, adipose dysfunction, insulin resistance and type 2 diabetes: from genetic discovery to biological mechanisms and translation.MRC · Research Grant · 2012-09-30 – 2015-08-30 · with 14 other participants£605,221whole project
KLF14, adipose dysfunction, insulin resistance and type 2 diabetes: from genetic discovery to biological mechanisms and translation.
MRC · Research Grant · 2012-09-30 – 2015-08-30 · with 14 other participants
£605,221
whole project
University Of OxfordleadBroad InstituteEli Lilly & Company LtdF. Hoffmann-La Roche AGIcahn School of Medicine at Mount SinaiKing's College HospitalLund UniversityNovo NordiskSanofiUniversity of California, Los Angeles (UCLA)University of ChicagoUniversity of Eastern FinlandUniversity of GenevaUniversity of PennsylvaniaWellcome Sanger Institute
Consortium BuildingMRC · Research Grant · 2012-09-30 – 2013-03-31 · with 21 other participants£20,000whole project
Consortium Building
MRC · Research Grant · 2012-09-30 – 2013-03-31 · with 21 other participants
£20,000
whole project
University Of ManchesterleadAbbVie IncAstrazenecaBecton, Dickinson and CompanyBristol-Myers SquibbBritish Association of Dermatologists (BAD)Eli Lilly & Company LtdGlaxoSmithKline (GSK)Guy's and St Thomas' NHS Foundation TrustJohnson & JohnsonKing'S College LondonLEO PharmaNewcastle UniversityNHS Greater Glasgow and Clyde (NHSGGC)NovartisPfizer IncQiagenQueen Mary University of LondonRoyal College of Physicians of LondonSanquinThe Psoriasis AssociationUniversity of Liverpool
Novel strategies to control virus infection and diseaseBBSRC · Institute Project · 2012-03-31 – 2017-03-30 · with 18 other participants£1,042,337whole project
Novel strategies to control virus infection and disease
BBSRC · Institute Project · 2012-03-31 – 2017-03-30 · with 18 other participants
£1,042,337
whole project
University Of EdinburghleadEco Animal Health LtdEli Lilly & Company LtdFree University of BerlinGenus plcInternational Livestock Research Institute (ILRI)Iowa State UniversityKaryopharm TherapeuticsMakerere UniversityNational Academy of Sciences of the Republic of ArmeniaOxford Nanopore TechnologiesScotland's Rural CollegeSokoine University of AgricultureThe Pirbright InstituteUniversity of Maryland, College ParkUniversity of the Philippines MindanaoU.S. Department of Agriculture USDAVirginia TechZoetis
The molecular frontier: extending the boundaries of process designEPSRC · Fellowship · 2012-02-25 – 2017-08-23 · with 7 other participants£1,278,003whole project
The molecular frontier: extending the boundaries of process design
EPSRC · Fellowship · 2012-02-25 – 2017-08-23 · with 7 other participants
£1,278,003
whole project
Imperial College LondonleadArgonne National LaboratoryCarnegie Mellon UniversityEli Lilly & Company LtdIndian Institute of Technology BombayProcter & Gamble Limited (P&G UK)SyngentaSyngenta International AG
EPSRC Centre for Innovative Manufacturing in Emergent Macromolecular TherapiesEPSRC · Research Grant · 2011-09-30 – 2016-12-31 · with 48 other participants£5,840,286whole project
EPSRC Centre for Innovative Manufacturing in Emergent Macromolecular Therapies
EPSRC · Research Grant · 2011-09-30 – 2016-12-31 · with 48 other participants
£5,840,286
whole project
University College LondonleadAegis AnalyticalAegis Analytical CorpAssociation of the British Pharmaceutical IndustryAstrazenecaAstraZenecaAvacta GroupAvacta Group PLCBioindustry AssociationBiopharm ServicesBiopharm Services LimitedBtgBtg PLC (UK)Celltech Group plcEDEN BiodesignEli Lilly & Company LtdEli Lilly S.A. - Irish BranchFrancis BiopharmaFrancis Biopharma LtdFujifilmGE HealthcareGE Healthcare LimitedGskHealth Protection AgencyHealthTech and Medicines Knowledge Transfer Network (Health KTN)Innovate UKLgc LtdLonza Biologics PLCLonza GroupMedicines & Healthcare pdts Reg Acy MHRAMerckMerck Sharpe and DohmeMSD Biologics UK LtdNational Institute for Biological Standards and Control (NIBSC)NHS EnglandNovo NordiskNovo Nordisk A/SNovozymes Biopharma UK LtdOffice of Health Economics (OHE)Pall EuropePfizerPfizer IncPolythericsPublic Health EnglandSyntaxin LtdTAP BiosystemsThe Association of the British Pharm IndUcb SAUK BioIndustry Association (BIA)
A novel role for the chemokine lymphotactin and its receptor in trigeminal sensitisationBBSRC · Research Grant · 2011-08-31 – 2015-08-30 · with 2 other participants£384,663whole project
A novel role for the chemokine lymphotactin and its receptor in trigeminal sensitisation
BBSRC · Research Grant · 2011-08-31 – 2015-08-30 · with 2 other participants
£384,663
whole project
Stem Cells, Prion Proteins and Alzheimer's Diseases: A Prion Chemical Biology Network (PCBNet)EPSRC · Research Grant · 2011-04-30 – 2013-10-31 · with 6 other participants£184,207whole project
Stem Cells, Prion Proteins and Alzheimer's Diseases: A Prion Chemical Biology Network (PCBNet)
EPSRC · Research Grant · 2011-04-30 – 2013-10-31 · with 6 other participants
£184,207
whole project
University of SheffieldleadAmorfix Life Sciences LtdCentre of Integrated Drug and Biomarker DiscoveryEli Lilly & Company LtdRetrogenixUniversity of California, San FranciscoUtrecht University
Dissecting populations of PrRP neurone in conditional transgenic miceBBSRC · Research Grant · 2010-05-03 – 2013-05-02 · with 4 other participants£419,384whole project
Dissecting populations of PrRP neurone in conditional transgenic mice
BBSRC · Research Grant · 2010-05-03 – 2013-05-02 · with 4 other participants
£419,384
whole project
University Of ManchesterleadEli Lilly & Company LtdEli Lilly (United Kingdom)Novo NordiskUniversity of Michigan
Elucidation of the role of kainate receptor subtypes in hippocampal synaptic function using novel pharmacological toolsBBSRC · Research Grant · 2008-03-01 – 2011-02-28 · with 1 other participant£694,029whole project
Elucidation of the role of kainate receptor subtypes in hippocampal synaptic function using novel pharmacological tools
BBSRC · Research Grant · 2008-03-01 – 2011-02-28 · with 1 other participant
£694,029
whole project
University of BristolleadEli Lilly & Company Ltd
Novel Analytical Instrumentation to Detect Aggregation in Biopharmaceutical ProcessingInnovate UK · Collaborative R&D · 2008-02-01 – 2010-10-31 · with 5 other participants£0awarded
Novel Analytical Instrumentation to Detect Aggregation in Biopharmaceutical Processing
Innovate UK · Collaborative R&D · 2008-02-01 – 2010-10-31 · with 5 other participants
£0
awarded
Eli Lilly & Company Limited£0
Evaluation and further development of small molecule probes to study the role of prion protein in the ageing and renewal of stem cellsBBSRC · Research Grant · 2007-05-31 – 2010-09-29 · with 4 other participants£630,740whole project
Evaluation and further development of small molecule probes to study the role of prion protein in the ageing and renewal of stem cells
BBSRC · Research Grant · 2007-05-31 – 2010-09-29 · with 4 other participants
£630,740
whole project
University of SheffieldleadAmorfix Life Sciences LtdEli Lilly & Company LtdUniversity of California, San FranciscoUtrecht University